查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018374

美國X光系統市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途和細分市場預測（2026-2033年）

U.S. Fluoroscopy Systems Market Size, Share & Trends Analysis Report By Product (Dedicated Urology Fluoroscopy Tables, Fixed Multipurpose Fluoroscopy for Urology), By Application, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國X光系統市場概述

據估計，2025年美國X光系統市值為1.633億美元，預計到2033年將達到2.175億美元。

我們預計從 2026 年到 2033 年，年複合成長率將達到 4.2%。這一強勁成長是由診斷和介入手術中對即時、精確成像的需求不斷成長所驅動的。

醫療機構越來越重視精準治療，尤其是在循環系統、整形外科和胃腸病學等領域，螢光在這些領域中發揮著至關重要的作用。微創手術日益受到青睞，進一步推動了螢光系統的應用，因為這些技術能夠提供更清晰的視野，並有望透過縮短恢復時間來改善患者預後。腎臟和泌尿系統疾病的日益普遍，對美國透視系統市場的成長起到了重要作用。透視技術可在微創手術過程中提供即時視覺化，使醫生能夠精準地引導導管、支架和其他器械。由於慢性腎臟病和泌尿系統疾病持續影響美國相當一部分人口，醫療機構越來越依賴透視系統來支持安全有效的手術介入。根據美國疾病管制與預防中心 (CDC) 於 2024 年 5 月發布的報告《2023 年美國慢性腎臟病》，預計屆時美國將有超過七分之一的成年人（約 3550 萬人）患有慢性腎臟病，這凸顯了日益沉重的醫療負擔。 CDC 也指出，許多患者尚未確診，因此亟需早期檢測和影像引導下的臨床介入。這種疾病盛行率的上升凸顯了對先進診斷和治療技術日益成長的需求，包括用於微創腎臟和泌尿系統手術的透視系統。

尤其在泌尿系統領域，透視技術廣泛應用於腎結石、泌尿道阻塞及相關疾病的微創手術。腎結石是一種常見疾病，需要影像導引進行治療方案製定和手術操作。根據美國國家糖尿病、胃腸和腎臟疾病研究所 (NIDDK) 的數據顯示，美國約有 11% 的男性和 6% 的女性一生中至少會患一次腎結石。透視技術可以幫助泌尿系統在輸尿管鏡檢查和支架置入等手術過程中即時觀察泌尿道情況，從而降低手術的複雜性並實現精準的器械操作。隨著這些疾病發生率的增加，透視技術在泌尿系統常規實踐中的應用也不斷擴展。

另一個重要因素是泌尿系統疾病治療中對高效率、微創方法的需求日益成長，而透視在其中發揮核心作用。泌尿系統專科機構的臨床指引強調最佳化術中透視，以在控制輻射暴露的同時改善治療效果，這反映出透視引導在現代泌尿系統工作流程中的重要性。即時成像使醫生能夠在手術過程中減輕組織負擔並縮短手術時間，這對於複雜的腎臟和泌尿系統手術尤其有利。對這類手術日益成長的依賴性直接推動了對適用於泌尿系統環境的先進透視系統的需求。

此外，近期人口預測顯示老年人口將持續成長，這將推動對支持高效精準治療流程的影像系統的長期需求。皮尤研究中心2024年1月發布的一份報告預測，美國百歲及以上老人的數量將從2024年的約10.1萬人增加到2054年的約42.2萬人，凸顯了人口結構向老齡化社會的顯著長期轉變。這一趨勢反映了美國更廣泛的老化趨勢，預計未來幾十年65歲及以上成年人的數量也將顯著增加。老年人口的成長正在推動對醫療保健服務的需求，包括微創手術和由透視等技術支援的影像引導手術。

目錄

第1章：美國靈媒系統市場：調查方法與範圍

第2章：美國X光視覺系統市場：執行摘要

  • 市場概覽
  • 細分市場概覽
  • 競爭格局概述

第3章：美國靈媒系統市場：變數、趨勢與範圍

  • 市場譜系展望
  • 採用率和成長前景圖
  • 產業價值鏈分析
  • 市場動態
  • 美國X光系統市場分析工具

第4章：美國X光系統市場：產品具體估算與趨勢分析

  • 產品特定波動分析、市場佔有率、2025 年及 2033 年
  • 市場規模、預測與趨勢分析：按產品分類，2021-2033 年
  • 泌尿系統透視台
  • 用於泌尿系統的固定式多功能透視設備

第5章：美國X光系統市場：按應用分類的估算與趨勢分析

  • 基於應用領域的波動分析、市場佔有率、2025 年及 2033 年
  • 市場規模、預測與趨勢分析：按應用領域分類，2021-2033年
  • 上泌尿道影像學檢查
  • 內視鏡泌尿系統和結石治療程序
  • 下泌尿道檢查
  • 介入泌尿系統
  • 後續觀察期間的透視檢查

第6章：美國X光系統市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測和趨勢分析：按最終用途分類，2021-2033 年
  • 醫院
    • 營利組織
    • 非營利組織
  • 專業醫療中心
  • 門診部
  • 其他

第7章 競爭情勢

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • GE HealthCare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems
    • Shimadzu Corporation
    • Dornier MedTech
    • UMG/DEL MEDICAL
Product Code: GVR-4-68040-874-7

U.S. Fluoroscopy Systems Market Summary

The U.S. fluoroscopy systems market size was estimated at USD 163.3 million in 2025 and is projected to reach USD 217.5 million by 2033, growing at a CAGR of 4.2% from 2026 to 2033. This robust growth is driven by the increasing demand for real-time and accurate imaging in diagnostic and interventional procedures.

Healthcare providers are focusing more on precision-based treatments, especially in areas such as cardiology, orthopedics, and gastroenterology, where fluoroscopy plays a critical role. The growing preference for minimally invasive procedures is further boosting the adoption of fluoroscopy systems, as these technologies enable better visualization and improved patient outcomes with shorter recovery times. The rising prevalence of kidney and urinary tract diseases plays critical role in the growth of U.S. fluoroscopy systems market. Fluoroscopy provides real-time visualization during minimally invasive procedures, allowing physicians to guide catheters, stents, and other instruments with precision. As chronic kidney disease and urinary disorders continue to affect a significant portion of the U.S. population, healthcare facilities increasingly depend on fluoroscopy systems to support safe and efficient interventions. According to the Centers for Disease Control and Prevention (CDC) report "Chronic Kidney Disease in the United States, 2023," published in May 2024, more than 1 in 7 U.S. adults (about 35.5 million people) are estimated to have chronic kidney disease, highlighting a significant and growing healthcare burden. The CDC also notes that many individuals remain undiagnosed, increasing the need for early detection and image-guided clinical interventions. This rising disease prevalence supports growing demand for advanced diagnostic and treatment technologies, including fluoroscopy systems used in minimally invasive kidney and urinary tract procedures.

In urology specifically, fluoroscopy is widely used in minimally invasive procedures for kidney stones, urinary obstructions, and related disorders. Kidney stones are a common condition requiring imaging guidance for treatment planning and intervention, and NIDDK notes that about 11% of men and 6% of women in the U.S. experience kidney stones at least once during their lifetime. Fluoroscopy helps urologists visualize the urinary tract in real time during procedures such as ureteroscopy and stent placement, enabling precise instrument navigation while reducing procedural complexity. As the incidence of these conditions rises, the use of fluoroscopy in routine urology practice continues to expand.

Another important factor is that urologic diseases increasingly require efficient, minimally invasive treatment approaches where fluoroscopy plays a central role. Clinical guidance from professional urology organizations emphasizes optimized fluoroscopy use during surgery to improve outcomes while managing radiation exposure, reflecting how essential fluoroscopic guidance has become in modern urologic workflows. Real-time imaging allows physicians to reduce surgical trauma and procedure time, which is particularly valuable for complex kidney and urinary tract interventions. This growing procedural reliance directly supports demand for advanced fluoroscopy systems tailored for urology settings.

Recent population estimates also show a continuing rise in the older age group, reinforcing long-term demand for imaging systems that support efficient and precise treatment workflows. According to a Pew Research Center report published in January 2024, the U.S. centenarian population (people aged 100 and older) is projected to grow from about 101,000 in 2024 to nearly 422,000 by 2054, highlighting a significant long-term demographic shift toward an older population. This trend reflects broader aging dynamics in the U.S., where the number of adults aged 65 and above is also expected to rise substantially over the coming decades. This growing elderly population increases demand for healthcare services, including minimally invasive and image-guided procedures supported by technologies such as fluoroscopy.

U.S. Fluoroscopy Systems Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. fluoroscopy systems market report based on product, application, and end use.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Dedicated urology fluoroscopy tables
  • Fixed multipurpose fluoroscopy for Urology
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Upper Urinary Tract Imaging & Diagnostics
  • Endourology & Stone Management Procedures
  • Lower Urinary Tract Studies
  • Interventional Urology
  • Post-operative/Follow-up Fluoroscopic Assessments
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
    • Not-for-Profit
    • For Profit
  • Specialty Centers
  • Ambulatory/Outpatient Centers
  • Others

Table of Contents

Chapter 1. U.S. Fluoroscopy Systems Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. U.S. Fluoroscopy Systems Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Fluoroscopy Systems Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. U.S. Fluoroscopy Systems Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat of New Entrants
      • 3.5.1.5. Competitive Rivalry
    • 3.5.2. PESTLE Analysis

Chapter 4. U.S. Fluoroscopy Systems Market: Product Estimates & Trend Analysis

  • 4.1. Product Movement Analysis & Market Share, 2025 & 2033
  • 4.2. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.3. Dedicated Urology Fluoroscopy Tables
    • 4.3.1. Dedicated Urology Fluoroscopy Tables Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.4. Fixed Multipurpose Fluoroscopy for Urology
    • 4.4.1. Fixed Multipurpose Fluoroscopy for Urology Market Estimates & Forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Fluoroscopy Systems Market: Application Estimates & Trend Analysis

  • 5.1. Application Movement Analysis & Market Share, 2025 & 2033
  • 5.2. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.3. Upper Urinary Tract Imaging & Diagnostics
    • 5.3.1. Upper Urinary Tract Imaging & Diagnostics Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Endourology & Stone Management Procedures
    • 5.4.1. Endourology & Stone Management Procedures Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Lower Urinary Tract Studies
    • 5.5.1. Lower Urinary Tract Studies Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Interventional Urology
    • 5.6.1. Interventional Urology Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Post-operative/Follow-up Fluoroscopic Assessments
    • 5.7.1. Post-operative/Follow-up Fluoroscopic Assessments Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Fluoroscopy Systems Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2025 & 2033
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. For-Profit
      • 6.4.2.1. For-Profit Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Not-for-Profit
      • 6.4.3.1. Not-for-Profit Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Specialty Centers
    • 6.5.1. Specialty Centers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ambulatory/Outpatient Centers
    • 6.6.1. Ambulatory/Outpatient Centers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. GE HealthCare
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Siemens Healthineers AG
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Koninklijke Philips N.V.
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Canon Medical Systems
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Shimadzu Corporation
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Dornier MedTech
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. UMG / DEL MEDICAL
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. U.S. fluoroscopy systems market, By product, 2021 - 2033 (USD Million)
  • Table 4. U.S. fluoroscopy systems market, By application, 2021 - 2033 (USD Million)
  • Table 5. U.S. fluoroscopy systems market, By end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 U.S. fluoroscopy systems market dynamics
  • Fig. 11 U.S. fluoroscopy systems market: Porter's five forces analysis
  • Fig. 12 U.S. fluoroscopy systems market: PESTLE analysis
  • Fig. 13 U.S. fluoroscopy systems market: product movement analysis
  • Fig. 14 U.S. fluoroscopy systems market: product outlook and key takeaways
  • Fig. 15 Dedicated urology fluoroscopy tables market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Fixed multipurpose fluoroscopy for urology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. fluoroscopy systems market: application movement analysis
  • Fig. 18 U.S. fluoroscopy systems market: application outlook and key takeaways
  • Fig. 19 Upper urinary tract imaging & diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Endourology & stone management procedures market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Lower urinary tract studies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Interventional urology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Post-operative/follow-up fluoroscopic assessments market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. fluoroscopy systems market: End use movement analysis
  • Fig. 25 U.S. fluoroscopy systems market: End use outlook and key takeaways
  • Fig. 26 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Not-for-Profit market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 For Profit market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Specialty centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Ambulatory/outpatient centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2021 - 2033 (USD Million)